Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Innovation Pharmaceuticals Inc IPIX

Innovation Pharmaceuticals Inc. is a clinical stage pharmaceutical company developing therapies with anti-infective, oncology, anti-inflammatory and dermatology applications. The Company’s lead drug candidate, Brilacidin, is in a class of compounds called defensin-mimetics, small compounds that mimic the structure and function of defensins, also known as host defense peptides. The Company is primarily focused on business development for the advancement of Brilacidin in the treatment of infectious diseases and oral mucositis. Its ongoing activities include Brilacidin drug manufacturing, scientific report writing, and supportive research activities. Brilacidin is also developed as a treatment in more extensive forms of inflammatory bowel disease (IBD). It is engaged in developing an image guided surgical laser platform, through BT BeaMedical Technologies Ltd. It is also engaged in business development and licensing initiatives with specialty and global pharmaceutical companies.


GREY:IPIX - Post by User

Post by kaos12on Apr 24, 2018 1:26pm
77 Views
Post# 27933040

Ok, here’s the deal.........

Ok, here’s the deal.........You don’t hire a manufacturer to produce something that has not been proven or just needs a little fixing. Take a look at Evonik for heavens sake. This is not a fly by night outfit. Only two plus billion dollars in profit last year. Do you really think these guys would take on something that isn’t proven already. This just verified that Brilacidin is a go. That’s one pipeline down and two to go. Prurisol will be the second pipeline shortly and shouldn’t be long for the last drug (can’t remember name) to be in the works as well considering all of the NO failed trials. Wish I wasn’t all in or I would be backing up the truck. This is a no brainer, but the shorts are gaming us and stopping and/ or impeding needed drugs to some very sick people- scumbags!
<< Previous
Bullboard Posts
Next >>